|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.91 HKD | -0.93% |
|
-1.97% | -34.20% |
| 06-25 | 3Sbio Inc. Declares a Final Dividend for the Year Ended 31 December 2025 | CI |
| 05-28 | Innovent Biologics, Pfizer strike $10.5 bln cancer drug deal amid China biotech boom | RE |
| Market Cap | 34.51B 39.79B 5.07B 4.45B 4.1B 3.84B 7.2B 479B 7.35B 49.28B 19.07B 237B 19.05B 18.63B 820B | P/E 2026 * |
12.6x | P/E 2027 * | 11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 21.95B 25.3B 3.23B 2.83B 2.61B 2.44B 4.58B 304B 4.67B 31.34B 12.13B 150B 12.12B 11.85B 522B | EV / Sales 2026 * |
2.1x | EV / Sales 2027 * | 1.78x |
| Free-Float |
75.09% | Yield 2026 * |
1.78% | Yield 2027 * | 1.97% |
| 1 day | -0.93% | ||
| 1 week | -1.97% | ||
| Current month | -14.00% | ||
| 1 month | -14.74% | ||
| 3 months | -33.65% | ||
| 6 months | -38.52% | ||
| Current year | -34.20% |
| 1 week | 15.4 |  | 17.35 |
| 1 month | 14.81 | | 20.2 |
| Current year | 14.81 | | 29.3 |
| 1 year | 14.81 | | 36.8 |
| 3 years | 4.91 | | 36.8 |
| 5 years | 4.72 | | 36.8 |
| 10 years | 4.72 | | 36.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jing Lou
CEO | Chief Executive Officer | 63 | 2005-12-31 |
Xiang He
DFI | Director of Finance/CFO | - | 2023-07-02 |
Dong Mei Su
PRN | Corporate Officer/Principal | 56 | 2014-11-26 |
| Director | Title | Age | Since |
|---|---|---|---|
Jing Lou
CHM | Chairman | 63 | 2012-04-02 |
Dong Mei Su
BRD | Director/Board Member | 56 | 2012-06-10 |
Tian Ruo Pu
BRD | Director/Board Member | 57 | 2015-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-07 | Other | Chief Executive Officer | 516,000 | 0.0203% | ||
| 25-07-28 | Other | Chief Executive Officer | 440,000 | 0.0184% | ||
| 25-04-14 | Other | Director | 26,000 | 0.0011% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.93% | -1.97% | -29.91% | +111.57% | 5.07B | |
| +2.06% | +3.76% | +21.48% | -11.62% | 64.39B | |
| +0.74% | +3.52% | +51.88% | +225.16% | 56.12B | |
| -3.10% | +34.30% | +34.30% | +34.30% | 40.54B | |
| -2.36% | -1.25% | -50.98% | -58.84% | 37.98B | |
| +6.97% | +9.89% | +71.34% | -23.65% | 31.89B | |
| +12.59% | +5.18% | +147.68% | -44.25% | 26.69B | |
| +5.78% | +15.81% | +66.37% | +84.42% | 22.73B | |
| -1.25% | -1.31% | -2.84% | +151.34% | 16.66B | |
| -0.81% | +5.91% | +63.81% | +125.65% | 16.6B | |
| Average | +1.97% | +3.69% | +37.31% | +59.41% | 31.87B | |
| Weighted average by Cap. | +1.91% | +4.01% | +38.70% | +50.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.45B 12.04B 1.54B 1.35B 1.24B 1.16B 2.18B 145B 2.22B 14.92B 5.77B 71.59B 5.77B 5.64B 248B | 11.29B 13.02B 1.66B 1.46B 1.34B 1.26B 2.35B 157B 2.4B 16.12B 6.24B 77.38B 6.23B 6.1B 268B |
| Net income | 2.83B 3.26B 415M 364M 336M 314M 590M 39.19B 602M 4.04B 1.56B 19.37B 1.56B 1.53B 67.17B | 2.95B 3.4B 434M 380M 351M 328M 616M 40.93B 628M 4.22B 1.63B 20.23B 1.63B 1.59B 70.15B |
| Net Debt | -12.56B -14.48B -1.85B -1.62B -1.49B -1.4B -2.62B -174B -2.68B -17.94B -6.94B -86.11B -6.94B -6.78B -299B | -14.36B -16.56B -2.11B -1.85B -1.71B -1.6B -3B -199B -3.06B -20.51B -7.94B -98.44B -7.93B -7.76B -341B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-26 | HK$15.91 | -0.93% | 25,420,952 |
| 26-06-25 | HK$16.06 | -2.19% | 32,683,363 |
| 26-06-24 | HK$16.42 | -0.06% | 35,488,388 |
| 26-06-23 | HK$16.43 | +2.11% | 27,473,143 |
| 26-06-22 | HK$16.09 | -0.86% | 23,896,666 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 1530 Stock
Select your edition
All financial news and data tailored to specific country editions
